Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Combo Products GMP Guidance Fills In Gaps On Drug-Delivery Device Compliance

This article was originally published in The Gray Sheet

Executive Summary

FDA has delivered a draft current good manufacturing practices guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device, drug/biological and drug/device/biological products.

Advertisement

Related Content

FDA Issues Final Guideline On Combination Product GMPs
2016 Will Be A Big Year For Combo Product Reform, FDA Says
2016 Will Be A Big Year For Combo Product Reform, FDA Says
Manufacturers Seek More Clarity On GMP Obligations For Combo Products
Device Industry Grab-Bag Of Provisions In 21st Century Cures Draft
Industry Seeks More Clarity Following Combo Product GMP Final Rule

Topics

Advertisement
UsernamePublicRestriction

Register

MT034439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel